UBS Initiates Coverage On Scotts Miracle Gro with Buy Rating, Announces Price Target of $225
UBS analyst Peter Grom initiates coverage on Scotts Miracle Gro (NYSE:SMG) with a Buy rating and announces Price Target of $225.
UPDATE: Raymond James Earlier On Scotts Miracle Gro Price Target Trim: Despite Continued Strong Buy Rating, Trends In U.S. Consumer Segment Expected To Soften Considerably In 2H.
Despite Continued Strong Buy Rating, Trends In U.S. Consumer Segment Expected To Soften Considerably In 2H As Base Period Comparisons Become More Challenging And Raise Concerns Over 'Reversion To Mean' In
10 Biggest Price Target Changes For Wednesday
Wedbush boosted Microsoft Corporation (NASDAQ: MSFT) price target from $310 to $325. Microsoft shares slipped 0.1% to $265.48 in pre-market trading.
What Does Scotts Miracle Gro’s Debt Look Like?
Over the past three months, shares of Scotts Miracle Gro (NYSE:SMG) moved lower by 19.02%. Before having a look at the importance of debt, let us look at how much debt Scotts Miracle Gro has.
Raymond James Maintains Strong Buy on Scotts Miracle Gro, Lowers Price Target to $250
Raymond James analyst Joseph Altobello maintains Scotts Miracle Gro (NYSE:SMG) with a Strong Buy and lowers the price target from $305 to $250.
Cannabis Stock Gainers And Losers From June 2, 2021
GAINERS:
Sundial Growers (NASDAQ: SNDL) shares closed up 13% at $1.13
Scotts Miracle-Gro Posts Q2 Results, Hawthorne Cannabis Subsidiary Sales Increase 66% YoY To $364M
Scotts Miracle-Gro (NYSE: SMG) reported Wednesday that company-wide sales grew by 32% year-over-year reaching $1.83 billion in the second quarter.
For the first half of fiscal 2021, the company reported sales of $2.58 billion, up by 47% from $1.75 billion in sales posted a year ago.
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell
• Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.